WRK - Kuehn Law Encourages LABP WRK KAMN and TGAN Investors to Contact Law Firm | Benzinga
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Landos Biopharma, Inc. (NASDAQ:LABP) click to participate
AbbVie Inc. will acquire Landos for $20.42 per share in cash, and each share will come with a non-tradable contingent value right per share up to $11.14 in value, contingent upon reaching a ...